Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

59.58
-0.1200-0.20%
Post-market: 59.680.1000+0.17%17:00 EDT
Volume:12.99M
Turnover:772.15M
Market Cap:121.29B
PE:13.11
High:59.94
Open:59.10
Low:58.73
Close:59.70
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:1.07
T/O Rate:0.64%
Dividend:2.51
Dividend Rate:4.21%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.43
PE(LYR):17.22

Loading ...

Huang's $500 Billion Financing Plan Splits Markets: Asset Managers Rally as Tech Stocks Slide for Second Day

Deep News
·
Aug 12

Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Savara Q2 Loss Widens as Operating Expenses Rise

Reuters
·
Aug 12

Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports

TIPRANKS
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Legend Biotech Q2 Revenue Beats Estimates on Commercial Expansion

Reuters
·
Aug 11

$400 Billion Merger Talks Collapse: AstraZeneca and Bristol-Myers Squibb Negotiations Fall Apart

Deep News
·
Aug 11

Replimune Jumps After $150 Mln Equity Offering for Skin Cancer Drug

Reuters
·
Aug 11

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Bristol-Myers Squibb Company - Bms Expects to Create 2,000 Construction and Indirect Jobs Between 2027–2030

THOMSON REUTERS
·
Aug 10

Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas

THOMSON REUTERS
·
Aug 10

Bristol Myers to Build $2.3 Billion Manufacturing Site in Houston

Reuters
·
Aug 10

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

Dow Jones
·
Aug 08

Bristol-Myers Squibb Tracks Real-World Use of Luspatercept in Anemia Care

TIPRANKS
·
Aug 08

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

Dow Jones
·
Aug 07

CytomX Q2 Revenue Misses, Partly Hurt by Lower Research Activities in the Astellas Collaboration

Reuters
·
Aug 07

Prothena Publishes Corporate Overview Presentation on Protein-Dysregulation Drug Pipeline

Reuters
·
Aug 07

US FDA Approves Replimune's Skin Cancer Drug

Reuters
·
Aug 07

Prothena: May Earn $55 Mln Clinical Milestone Payment if Bristol Myers Squibb Decides to Advance Prx019 ; Bms Decision Expected Year End 2026

THOMSON REUTERS
·
Aug 07

Deal or no Deal, AstraZeneca Stock is a Bargain

Dow Jones
·
Aug 06